Gemcitabine Injection IP 1000 mg

Gemcitabine Injection IP 1000 mg

6000.00 - 6800.00 INR/Piece

Product Details:

  • Drug Type Injection
  • Ingredients Gemcitabine
  • Physical Form Powder
  • Storage Instructions 10-30C
  • Click to view more
X

Gemcitabine Injection IP 1000 mg Price And Quantity

  • 6000.00 - 6800.00 INR/Piece
  • INR/Piece
  • 50 PIECES Piece

Gemcitabine Injection IP 1000 mg Product Specifications

  • 10-30C
  • Powder
  • Injection
  • Gemcitabine

Gemcitabine Injection IP 1000 mg Trade Information

  • Telegraphic Transfer (T/T)
  • 200 Piece Per Month
  • 8 - 10 Days
  • Western Europe Australia Eastern Europe Middle East Central America South America Asia North America Africa

Product Description

Gemcitabine Injection IP refers to a medication containing the active ingredient gemcitabine hydrochloride, which is a chemotherapy drug used to treat various types of cancer. Gemcitabine is a nucleoside analog that interferes with the growth and spread of cancer cells in the body.

Gemcitabine is commonly used in the treatment of:

  • Pancreatic cancer
  • Non-small cell lung cancer
  • Breast cancer
  • Ovarian cancer
  • Bladder cancer
  • Soft tissue sarcoma
  • Hodgkin's and non-Hodgkin's lymphoma

Gemcitabine is typically administered intravenously (IV) by a healthcare professional in a clinical setting. It works by disrupting the process of DNA synthesis in cancer cells, ultimately leading to their death.

As with any chemotherapy drug, gemcitabine may cause side effects, which can vary from person to person and depending on the dose and duration of treatment. Common side effects may include nausea, vomiting, fatigue, hair loss, decreased blood cell counts (leading to increased risk of infection, anemia, or bleeding), and flu-like symptoms.
Enter Buying Requirement Details
Email Id
Mobile number

Other Products in 'Pharmaceutical Injection' category



Back to top
trade india member
NIBA HEALTHCARE All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.